Key facts
- This page summarizes Alexander K. Arrow's Form 4 filing for Protagenic Therapeutics, Inc.\new (PTIX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Oct 2023, 12:48.
Alexander K. Arrow - 12 Oct 2023 Form 4 Insider Report for Protagenic Therapeutics, Inc.\new (PTIX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- PTIX
- Reported as of
- 12 Oct 2023
- Net transaction value
- +$6,480
- SEC form
- 4
- Accepted by SEC
- 13 Oct 2023, 12:48:45 UTC
- Prior SEC filing
- 25 Nov 2022
- Next SEC filing
- 29 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alexander K Arrow
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alexander K. Arrow filed Form 4 for Protagenic Therapeutics, Inc.\new (PTIX) on 13 Oct 2023.
Change
- Previous filing in this sequence was filed on 25 Nov 2022.
- Current net transaction value: +$6,480.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTIX
transaction
PTIX Common Stock
Purchase
- Transaction value
- $6,480
- Shares
- +8,000
- Change %
- +21%
- Price
- $0.8100
- Shares after
- 45,815
- Date
- 12 Oct 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.